Oak Street Health Announces Secondary Offering
Oak Street Health (NYSE: OSH) has initiated an underwritten public offering of 10,000,000 shares of common stock by certain selling stockholders, who may grant underwriters a 30-day option to purchase an additional 1,500,000 shares. Oak Street will not receive proceeds from this sale. The offering is managed by J.P. Morgan, Goldman Sachs, Morgan Stanley, and William Blair. A registration statement has been filed with the SEC but remains ineffective. This press release does not constitute an offer to sell or solicit securities.
- Initiation of public offering of 10,000,000 shares allows selling stockholders to raise capital.
- Involvement of reputable underwriters (J.P. Morgan, Goldman Sachs, Morgan Stanley, William Blair) enhances credibility.
- Oak Street will not benefit from the proceeds of the stock sale, which could limit its financial flexibility.
- The offering may signal dilution concerns for existing shareholders.
Oak Street Health, Inc. (NYSE: OSH, or the “Company”), a network of value-based primary care centers for adults on Medicare, today announced the commencement of an underwritten public offering of 10,000,000 shares of its common stock by certain selling stockholders. Such selling stockholders also intend to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of Oak Street’s common stock. Oak Street will not receive any of the proceeds from the sale of the shares of its common stock being offered by the selling stockholders, and the selling stockholders will bear the costs associated with the sale of such shares, including underwriting discounts and commissions.
J.P. Morgan, Goldman Sachs & Co. LLC, Morgan Stanley and William Blair are acting as joint book running managers for the proposed offering.
The proposed offering of common stock will be made only by means of a prospectus. When available, copies of the preliminary prospectus relating to the offering may be obtained from: J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: 1-866- 803-9204 or email at prospectus-eq_fi@jpmchase.com; or Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, via telephone: 1-866-471-2526, or via email: prospectus-ny@ny.email.gs.com; or Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, Second Floor, New York, New York 10014; or William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606; via telephone at (800) 621-0687 or via email: prospectus@williamblair.com.
A registration statement on Form S-1 relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Oak Street Health:
Founded in 2012, Oak Street Health is a network of value-based primary care centers for adults on Medicare. With a mission of rebuilding healthcare as it should be, the Company operates an innovative healthcare model focused on quality of care over volume of services, and assumes the full financial risk of its patients. Oak Street Health currently operates more than 85 centers across 13 states.
Forward-Looking Statements
Certain of the statements made in this press release are forward looking within the meaning of the Private Securities Litigation Reform Act of 1995, such as those, among others, statements concerning the expected closing of the offering. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include, without limitation, risks and uncertainties related to the satisfaction of customary closing conditions related to the offering and the impact of general economic, industry or political conditions in the United States or internationally. There can be no assurance that Oak Street will be able to complete the offering on the anticipated terms, or at all. You should not place undue reliance on these forward-looking statements as predictions of future events, which statements apply only as of the date of this press release. Additional risks and uncertainties relating to the offering, Oak Street and its business can be found under the heading "Risk Factors" in Oak Street’s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q and in the S-1 for this offering, filed with the Securities and Exchange Commission. Forward-looking statements represent Oak Street’s beliefs and assumptions only as of the date of this press release. Oak Street expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based, except as may be required under applicable law.
Source: Oak Street Health
View source version on businesswire.com: https://www.businesswire.com/news/home/20210524005814/en/
FAQ
What is the purpose of Oak Street Health's stock offering?
How many additional shares can underwriters purchase in the Oak Street offering?
Will Oak Street Health receive proceeds from the stock offering?
Who are the underwriters for Oak Street Health's public offering?
What does the SEC registration statement for Oak Street Health indicate?
